
Bio-Rad Laboratories, Inc.: shareholders and insiders
Price
$369.75
November 18, 2026Market cap $10.1B
What Ploutos Investor adds for Bio-Rad Laboratories
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Nov 12, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$1.4M
4 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $1.4M by 4 people
- 2025: no buys, no sales
- 2026: no buys, sold $1.4M by 4 people
- Nov 10, 2026Courtney C EnloeEVP, General Counsel & SecKind
- Nov 9, 2026Jonathan P. DiVincenzoPresident & COOKind
- Nov 9, 2026James BarryEVP, President, LSGKind
- Oct 24, 2026Jonathan P. DiVincenzoPresident & COOKind
- Oct 24, 2026Jonathan P. DiVincenzoPresident & COOKind
- Oct 20, 2026Sedat EvranEVP, Global Supply ChainKind
- Oct 20, 2026Sedat EvranEVP, Global Supply ChainKind
- Sep 6, 2026Schwartz AllisonDirectorKind
- Sep 6, 2026Schwartz AllisonDirectorKind
- Sep 6, 2026James BarryEVP, President, LSGKind
- Sep 6, 2026James BarryEVP, President, LSGKind
- Sep 6, 2026Sedat EvranEVP, Global Supply ChainKind
- Sep 6, 2026Sedat EvranEVP, Global Supply ChainKind
- Sep 6, 2026Eva Anette EngelhardtEVP, President, CDGKind
- Sep 6, 2026Eva Anette EngelhardtEVP, President, CDGKind
- Sep 6, 2026Courtney C EnloeEVP, General Counsel & SecKind
- Sep 6, 2026Courtney C EnloeEVP, General Counsel & SecKind
- Sep 6, 2026Roop Kalyan LakkarajuEVP, Chief Financial OfficerKind
- Sep 6, 2026Roop Kalyan LakkarajuEVP, Chief Financial OfficerKind
- Sep 6, 2026Norman D SchwartzChairman & CEOKind
- Sep 6, 2026Norman D SchwartzChairman & CEOKind
- Sep 5, 2026Schwartz AllisonDirectorKind
- Sep 5, 2026Schwartz AllisonDirectorKind
- Sep 5, 2026James BarryEVP, President, LSGKind
- Sep 5, 2026James BarryEVP, President, LSGKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Courtney C EnloeEVP, General Counsel & Sec | 902 | $386.17 | $348.3K | Form 4 | |
| Nov 9, 2026 | Jonathan P. DiVincenzoPresident & COO | 919 | $390.47 | $358.8K | Form 4 | |
| Nov 9, 2026 | James BarryEVP, President, LSG | 1,400 | $385.63 | $539.9K | Form 4 | |
| Oct 24, 2026 | Jonathan P. DiVincenzoPresident & COO | 1,869 | – | – | Form 4 | |
| Oct 24, 2026 | Jonathan P. DiVincenzoPresident & COO | 951 | $369.95 | $351.8K | Form 4 | |
| Oct 20, 2026 | Sedat EvranEVP, Global Supply Chain | 1,044 | – | – | Form 4 | |
| Oct 20, 2026 | Sedat EvranEVP, Global Supply Chain | 487 | $354.50 | $172.6K | Form 4 | |
| Sep 6, 2026 | Schwartz AllisonDirector | 92 | – | – | Form 4 | |
| Sep 6, 2026 | Schwartz AllisonDirector | 34 | $386.11 | $13.1K | Form 4 | |
| Sep 6, 2026 | James BarryEVP, President, LSG | 1,056 | – | – | Form 4 | |
| Sep 6, 2026 | James BarryEVP, President, LSG | 470 | $386.11 | $181.5K | Form 4 | |
| Sep 6, 2026 | Sedat EvranEVP, Global Supply Chain | 864 | – | – | Form 4 | |
| Sep 6, 2026 | Sedat EvranEVP, Global Supply Chain | 277 | $386.11 | $107.0K | Form 4 | |
| Sep 6, 2026 | Eva Anette EngelhardtEVP, President, CDG | 1,152 | – | – | Form 4 | |
| Sep 6, 2026 | Eva Anette EngelhardtEVP, President, CDG | 485 | $386.11 | $187.3K | Form 4 | |
| Sep 6, 2026 | Courtney C EnloeEVP, General Counsel & Sec | 768 | – | – | Form 4 | |
| Sep 6, 2026 | Courtney C EnloeEVP, General Counsel & Sec | 305 | $386.11 | $117.8K | Form 4 | |
| Sep 6, 2026 | Roop Kalyan LakkarajuEVP, Chief Financial Officer | 1,536 | – | – | Form 4 | |
| Sep 6, 2026 | Roop Kalyan LakkarajuEVP, Chief Financial Officer | 782 | $386.11 | $301.9K | Form 4 | |
| Sep 6, 2026 | Norman D SchwartzChairman & CEO | 3,455 | – | – | Form 4 | |
| Sep 6, 2026 | Norman D SchwartzChairman & CEO | 1,854 | $386.11 | $715.8K | Form 4 | |
| Sep 5, 2026 | Schwartz AllisonDirector | 228 | – | – | Form 4 | |
| Sep 5, 2026 | Schwartz AllisonDirector | 82 | $386.11 | $31.7K | Form 4 | |
| Sep 5, 2026 | James BarryEVP, President, LSG | 1,027 | – | – | Form 4 | |
| Sep 5, 2026 | James BarryEVP, President, LSG | 369 | $386.11 | $142.5K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 28, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by BIO's officers and directors from 2004 up to November 17, 2025, 22 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 17 more, back to 2004
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Norman D. Schwartzwith 3 more personsClass B Common StockShare of class97.2%
- First Eagle Investment Management, LLCwith 1 more personCommonShare of class11.4%
- BlackRock, Inc.Class A StockShare of class7.40%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Norman D. Schwartzwith 3 more personsClass B Common Stock | 97.2% | 4.93M | Oct 30, 20255 filings since Jul 18, 2025 | 13D/A | |
| First Eagle Investment Management, LLCwith 1 more personCommon | 11.4% | 2.53M | Aug 6, 20253 filings since May 5, 2025 | 13G/A | |
| BlackRock, Inc.Class A Stock | 7.40% | 1.62M | Oct 17, 2025 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Norman D. Schwartz97.2%From the filing of Oct 30, 2025
Item 4 to the Schedule 13D is hereby amended, in pertinent part, as follows: The purpose of the Shareholders' ownership of Bio-Rad shares has been control of the Company. The Shareholders control the management of the Company and may be deemed to be "parents" of the Company as that term is defined in the Rules and Regulations of the Commission.
From the filing of Oct 30, 2025
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 26, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Greenlight / DME (Einhorn)In the quarter
- Millennium Mgmt (Englander)In the quarter+59%
- D.E. ShawIn the quarter+402%
- AQR CapitalIn the quarter-11%
- Bridgewater (Dalio)In the quarter
- Citadel Advisors (Griffin)In the quarter-68%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Greenlight / DME (Einhorn) | 104.0K | $39M | 1.11% | |
| Millennium Mgmt (Englander) | 95.4K | +59% | $36M | 0.03% |
| D.E. Shaw | 96.7K | +402% | $37M | 0.02% |
| AQR Capital | 172.3K | -11% | $65M | 0.02% |
| Bridgewater (Dalio) | 749 | $300.0K | 0.00% | |
| Citadel Advisors (Griffin) | 19.6K | -68% | $7.4M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 4.03% of its shares outstanding were held short, -7.2% since the report before.
- Shares held short
- 1.10M
- 4.03%
- Since the report before1.18M on Sep 30, 2026
- -7.2%
- 4.8
- 226.6K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 59%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 418.0K
- Nov 15, 2023: Shares held short 572.1K
- Nov 30, 2023: Shares held short 649.3K
- Dec 15, 2023: Shares held short 503.3K
- Dec 29, 2023: Shares held short 453.4K
- Jan 12, 2024: Shares held short 521.3K
- Jan 31, 2024: Shares held short 526.7K
- Feb 15, 2024: Shares held short 587.1K
- Feb 29, 2024: Shares held short 503.4K
- Mar 15, 2024: Shares held short 579.3K
- Mar 28, 2024: Shares held short 564.8K
- Apr 15, 2024: Shares held short 688.5K
- Apr 30, 2024: Shares held short 733.1K
- May 15, 2024: Shares held short 653.5K
- May 31, 2024: Shares held short 752.3K
- Jun 14, 2024: Shares held short 867.6K
- Jun 28, 2024: Shares held short 1.28M
- Jul 15, 2024: Shares held short 1.42M
- Jul 31, 2024: Shares held short 1.27M
- Aug 15, 2024: Shares held short 940.1K
- Aug 30, 2024: Shares held short 1.05M
- Sep 13, 2024: Shares held short 1.35M
- Sep 30, 2024: Shares held short 851.3K
- Oct 15, 2024: Shares held short 823.1K
- Oct 31, 2024: Shares held short 651.7K
- Nov 15, 2024: Shares held short 524.4K
- Nov 29, 2024: Shares held short 488.6K
- Dec 13, 2024: Shares held short 551.6K
- Dec 31, 2024: Shares held short 655.5K
- Jan 15, 2025: Shares held short 662.3K
- Jan 31, 2025: Shares held short 583.6K
- Feb 14, 2025: Shares held short 610.1K
- Feb 28, 2025: Shares held short 862.7K
- Mar 14, 2025: Shares held short 1.00M
- Mar 31, 2025: Shares held short 710.4K
- Apr 15, 2025: Shares held short 1.13M
- Apr 30, 2025: Shares held short 1.07M
- May 15, 2025: Shares held short 1.32M
- May 30, 2025: Shares held short 1.22M
- Jun 13, 2025: Shares held short 890.8K
- Jun 30, 2025: Shares held short 894.8K
- Jul 15, 2025: Shares held short 894.3K
- Jul 31, 2025: Shares held short 917.1K
- Aug 15, 2025: Shares held short 1.00M
- Aug 29, 2025: Shares held short 1.00M
- Sep 15, 2025: Shares held short 1.11M
- Sep 30, 2025: Shares held short 833.9K
- Oct 15, 2025: Shares held short 1.12M
- Oct 31, 2025: Shares held short 931.2K
- Nov 14, 2025: Shares held short 867.8K
- Nov 28, 2025: Shares held short 987.6K
- Dec 15, 2025: Shares held short 899.0K
- Dec 31, 2025: Shares held short 864.1K
- Jan 15, 2026: Shares held short 792.4K
- Jan 30, 2026: Shares held short 819.1K
- Feb 13, 2026: Shares held short 950.7K
- Feb 27, 2026: Shares held short 947.5K
- Mar 13, 2026: Shares held short 1.01M
- Mar 31, 2026: Shares held short 1.21M
- Apr 15, 2026: Shares held short 1.07M
- Apr 30, 2026: Shares held short 1.09M
- May 15, 2026: Shares held short 1.34M
- May 29, 2026: Shares held short 1.51M
- Jun 15, 2026: Shares held short 1.52M
- Jun 30, 2026: Shares held short 1.52M
- Jul 15, 2026: Shares held short 1.56M
- Jul 31, 2026: Shares held short 1.41M
- Aug 14, 2026: Shares held short 1.33M
- Aug 31, 2026: Shares held short 1.13M
- Sep 15, 2026: Shares held short 998.7K
- Sep 30, 2026: Shares held short 1.18M
- Oct 15, 2026: Shares held short 1.10M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading64.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 64.5% of the shares in the reported trades were short sales, against 65.3% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 64.5%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 65.3%
- Change
- -0.8 pts
- Short sales a dayon average, of 121.6K shares
- 78.4K
- More than atof 3,659 US-listed companies, same days
- 91%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 62.5%
- Oct 12, 2026: Short sales 74.2%
- Oct 13, 2026: Short sales 75.2%
- Oct 14, 2026: Short sales 42.4%
- Oct 15, 2026: Short sales 49.4%
- Oct 16, 2026: Short sales 77.6%
- Oct 19, 2026: Short sales 73.6%
- Oct 20, 2026: Short sales 48.8%
- Oct 21, 2026: Short sales 76.9%
- Oct 22, 2026: Short sales 79.5%
- Oct 23, 2026: Short sales 82.4%
- Oct 26, 2026: Short sales 70.3%
- Oct 27, 2026: Short sales 73.3%
- Oct 28, 2026: Short sales 52.7%
- Oct 29, 2026: Short sales 48.1%
- Oct 30, 2026: Short sales 67%
- Nov 2, 2026: Short sales 62.6%
- Nov 3, 2026: Short sales 67%
- Nov 4, 2026: Short sales 63.8%
- Nov 5, 2026: Short sales 59.7%
- Nov 6, 2026: Short sales 72.6%
- Nov 9, 2026: Short sales 60%
- Nov 10, 2026: Short sales 81%
- Nov 11, 2026: Short sales 65.4%
- Nov 12, 2026: Short sales 75.1%
- Nov 13, 2026: Short sales 61.1%
- Nov 16, 2026: Short sales 83.6%
- Nov 17, 2026: Short sales 71.8%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Norman D SchwartzChairman & CEODirectly4.96M
- Sedat EvranEVP, Global Supply ChainDirectly4,160
- Roop Kalyan LakkarajuEVP, Chief Financial OfficerDirectly4,150
- Jonathan P. DiVincenzoPresident & COODirectly1,962
- Eva Anette EngelhardtEVP, President, CDGDirectly1,828
- Schwartz AllisonDirectorDirectly1,734
- Rajat MehtaEVP, GBL Commercial OperationsDirectly1,232
- Courtney C EnloeEVP, General Counsel & SecDirectly749
- James BarryEVP, President, LSGDirectly624
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Norman D SchwartzChairman & CEO | 4.96M | – | Sep 6, 2026 | Form 4 |
| Sedat EvranEVP, Global Supply Chain | 4,160 | – | Oct 20, 2026 | Form 4 |
| Roop Kalyan LakkarajuEVP, Chief Financial Officer | 4,150 | – | Sep 6, 2026 | Form 4 |
| Jonathan P. DiVincenzoPresident & COO | 1,962 | – | Nov 9, 2026 | Form 4 |
| Eva Anette EngelhardtEVP, President, CDG | 1,828 | – | Sep 6, 2026 | Form 4 |
| Schwartz AllisonDirector | 1,734 | – | Sep 6, 2026 | Form 4 |
| Rajat MehtaEVP, GBL Commercial Operations | 1,232 | – | Sep 5, 2026 | Form 4 |
| Courtney C EnloeEVP, General Counsel & Sec | 749 | – | Nov 10, 2026 | Form 4 |
| James BarryEVP, President, LSG | 624 | – | Nov 9, 2026 | Form 4 |
A lower bound: it counts only the 9 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- DFSVDimensional US Small Cap Value ETFWeight in the fund0.47%
- FNDASchwab Fundamental U.S. Small Company ETFWeight in the fund0.28%
- IJKiShares S&P Mid-Cap 400 Growth ETFWeight in the fund0.15%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.15%
- IJHiShares Core S&P Mid-Cap ETFWeight in the fund0.15%
- SPMDState Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETFWeight in the fund0.15%
- MDYState Street SPDR S&P MidCap 400SM ETF TrustWeight in the fund0.14%
- SCHMSchwab U.S. Mid-Cap ETFWeight in the fund0.13%
- VBRVanguard Small-Cap Value Index FundWeight in the fund0.12%
- IYHiShares U.S. Healthcare ETFWeight in the fund0.10%
33 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 398
- Q4 2025: Managers 399
- Q1 2026: Managers 397
- Q2 2026: Managers 399
Institutional investors by quarter
The fund managers holding BIO, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 399 managers held 22.25M shares, worth $6.5B. During the quarter 60 opened a position, 58 closed one, 111 added and 152 trimmed.
The largest holders, Q2 2026
- First Eagle Investment ManagementIn the quarter+100%
- BlackRockIn the quarter+1.1%
- Dimensional Fund AdvisorsIn the quarter-13%
- Vanguard Capital ManagementIn the quarter-0.5%
- Ariel InvestmentsIn the quarter+3.9%
- Vanguard Portfolio ManagementIn the quarter-1.6%
- Earnest PartnersIn the quarter-1.4%
- State StreetIn the quarter+2.2%
- Bank of AmericaIn the quarter+10%
- Assenagon Asset ManagementIn the quarter+216%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| First Eagle Investment Management | 5.21M | +100% | $1.5B |
| BlackRock | 1.70M | +1.1% | $499M |
| Dimensional Fund Advisors | 944.5K | -13% | $277M |
| Vanguard Capital Management | 827.0K | -0.5% | $243M |
| Ariel Investments | 816.8K | +3.9% | $240M |
| Vanguard Portfolio Management | 816.2K | -1.6% | $240M |
| Earnest Partners | 580.8K | -1.4% | $171M |
| State Street | 571.8K | +2.2% | $168M |
| Bank of America | 490.4K | +10% | $144M |
| Assenagon Asset Management | 466.5K | +216% | $137M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Bio-Rad Laboratories's filings show?
Who buys and sells is one part of Bio-Rad Laboratories's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have BIO's insiders bought or sold?
From Jul 28, 2026 to Nov 12, 2026 Bio-Rad Laboratories's insiders bought 0 and sold $1.2M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold BIO?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $65M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.